• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

310
69
53
50
46

COUNTRY

30
13
12
11
11

PRICE

109
322
518
1,422

PUBLISHED

4
90
387
1,422

PRODUCT TYPE

1,290
97
17
16
2

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE
Swine Influenza - Pipeline Review, H2 2014 Swine Influenza - Pipeline Review, H2 2014 - Product Thumbnail Image

Swine Influenza - Pipeline Review, H2 2014

Swine Influenza - Pipeline Review, H2 2014 Summary This, ‘Swine Influenza - Pipeline Review, H2 2014’, provides an overview of the Swine Influenza’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM
Escherichia Coli Infections - Pipeline Review, H2 2014 Escherichia Coli Infections - Pipeline Review, H2 2014 - Product Thumbnail Image

Escherichia Coli Infections - Pipeline Review, H2 2014

Escherichia Coli Infections - Pipeline Review, H2 2014 Summary This, ‘Escherichia Coli Infections - Pipeline Review, H2 2014’, provides an overview of the Escherichia Coli Infections’s therapeutic...

November 2014
FROM
Human Papillomavirus Infections Pipeline Highlights - 2015 Human Papillomavirus Infections Pipeline Highlights - 2015 - Product Thumbnail Image

Human Papillomavirus Infections Pipeline Highlights - 2015

The latest report Human Papillomavirus Infections Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global Human Papillomavirus Infections market. It...

November 2014
FROM
HIV Pipeline Highlights - 2015 HIV Pipeline Highlights - 2015 - Product Thumbnail Image

HIV Pipeline Highlights - 2015

The latest report HIV Pipeline Highlights – 2015, provides most up-to-date information on key pipeline molecules in the global HIV market. It covers emerging therapies for HIV in active clinical development...

November 2014
FROM

Sepsis - Pipeline Review, H2 2014

Sepsis - Pipeline Review, H2 2014 Summary This, ‘Sepsis - Pipeline Review, H2 2014’, provides an overview of the Sepsis’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Aspergillosis - Pipeline Review, H2 2014

Aspergillosis - Pipeline Review, H2 2014 Summary This, ‘Aspergillosis - Pipeline Review, H2 2014’, provides an overview of the Aspergillosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Rabies - Pipeline Review, H2 2014

Rabies - Pipeline Review, H2 2014 Summary This, ‘Rabies - Pipeline Review, H2 2014’, provides an overview of the Rabies’s therapeutic pipeline. This report provides comprehensive information on the...

October 2014
FROM

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2014

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2014 Summary This, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2014’, provides an overview of the Chagas Disease...

October 2014
FROM

Ebola Viral Infections Global Clinical Trials Review, H2, 2014

Ebola Viral Infections Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Ebola Viral Infections Global Clinical Trials Review, H2, 2014" provides data on the Ebola Viral...

October 2014
FROM

Tuberculosis - Pipeline Review, H2 2014

Tuberculosis - Pipeline Review, H2 2014 Summary This, ‘Tuberculosis - Pipeline Review, H2 2014’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Hepatitis C - Pipeline Review, H2 2014

Hepatitis C - Pipeline Review, H2 2014 Summary This, ‘Hepatitis C - Pipeline Review, H2 2014’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Chikungunya - Pipeline Review, H2 2014

Chikungunya - Pipeline Review, H2 2014 Summary This, ‘Chikungunya - Pipeline Review, H2 2014’, provides an overview of the Chikungunya’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

HIV-1 Infection - Pipeline Review, H2 2014

HIV-1 Infection - Pipeline Review, H2 2014 Summary This, ‘HIV-1 Infection - Pipeline Review, H2 2014’, provides an overview of the HIV-1 Infection’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Gonorrhea - Pipeline Review, H2 2014

Gonorrhea - Pipeline Review, H2 2014 Summary This, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

Hand, Foot And Mouth Disease - Pipeline Review, H2 2014

Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary This, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2014’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic...

October 2014
FROM

Toxoplasmosis - Pipeline Review, H2 2014

Toxoplasmosis - Pipeline Review, H2 2014 Summary This, ‘Toxoplasmosis - Pipeline Review, H2 2014’, provides an overview of the Toxoplasmosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM
Competitor Analysis: Ebola Virus Vaccines and Therapeutics Competitor Analysis: Ebola Virus Vaccines and Therapeutics - Product Thumbnail Image

Competitor Analysis: Ebola Virus Vaccines and Therapeutics

The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the field of new molecules for prevention or treatment of Ebola...

October 2014
FROM
Competitor Analysis: Anti-Infective Peptides Competitor Analysis: Anti-Infective Peptides - Product Thumbnail Image

Competitor Analysis: Anti-Infective Peptides

The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective...

October 2014
FROM

H1N1 Infection - Pipeline Review, H2 2014

H1N1 Infection - Pipeline Review, H2 2014 Summary This, ‘H1N1 Infection - Pipeline Review, H2 2014’, provides an overview of the H1N1 Infection’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary This, ‘Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014’, provides...

September 2014
FROM
Loading Indicator

Our Clients

Genentech, Inc. GlaxoSmithKline PLC Maquet Getinge Group Emergent BioSolutions, Inc. Aicuris GmbH & Co.KG Merck & Co., Inc.